Viewing nowCombinationRivastat Tablet 10/20mg
Atorvastatin Calcium 21.7mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Palmgen Science Co., Ltd.

MFDS item code 202100199 · Approved 2021.01.08 · Insurance code 670105130
Improvement of cholesterol and lipid levels in hypercholesterolemia (primary, mixed type) and dyslipidemia.
This medication is used as an adjunct to dietary measures to lower elevated levels of total cholesterol, LDL cholesterol, Apo B, triglycerides, and non-HDL cholesterol in patients with primary hypercholesterolemia and mixed dyslipidemia, while increasing high-density lipoprotein (HDL) cholesterol. It particularly aids in lipid control in patients at increased risk for cardiovascular diseases, helping to maintain vascular health. This medication should be used alongside appropriate dietary adjustments and is given when other non-pharmacological therapies are insufficient. Before initiation, it is important to identify and treat other causes of dyslipidemia such as diabetes and hypothyroidism if necessary. Regular monitoring of cholesterol levels in patients is recommended to assess treatment progress. This medication is effective in treating dyslipidemia and is used to improve cholesterol levels.
This medication is taken once daily, regardless of meals. The dosage range for the treatment of primary hypercholesterolemia is 10/10mg to 10/40mg daily. The recommended initial dose is 10/10mg or 10/20mg daily. If a greater reduction in LDL cholesterol is required, the dosage may be adjusted. After initiation of treatment or dose adjustment, serum lipid levels should be checked after an interval of more than 2 weeks.
This medication may affect muscles, so if symptoms of muscle pain or weakness occur, one should consult a doctor immediately. There is a risk of serious side effects such as severe myopathy or rhabdomyolysis, which may lead to deterioration of renal function, thus patients with risk factors require caution. The medication may affect liver function, so regular liver function tests should be conducted before and during treatment. If symptoms of liver dysfunction or jaundice, nausea, vomiting, or malaise occur, treatment should be discontinued immediately and a doctor should be notified. Women who are pregnant or may become pregnant and nursing mothers should not take this medication, and fertile women should use adequate contraception. This medication is not to be administered to patients with certain liver diseases, muscle disorders, those taking Glecaprevir and Pibrentasvir, or lactose intolerant individuals. Alcoholics, patients with liver dysfunction, elderly individuals, and those with hypothyroidism should be especially cautious when using this medication, and dosage adjustments or regular testing may be needed. Additionally, this medication can interact with other drugs, so patients should inform their doctor or pharmacist of any medications being taken. Dizziness may occur while taking this medication, so caution is advised when driving or operating machinery. In the event of an overdose, as there is no specific antidote, symptomatic treatment and supportive care should be provided, and liver function and muscle-related tests should be carried out. Finally, this medication should be kept out of the reach of children and should not be transferred to other containers.
Rash, severe swelling (edema), chest tightness, difficulty breathing, cold sweats, pallor, severe rash with high fever, blisters, peeling skin, pain in mucous membranes of mouth/eyes, difficulty breathing or shortness of breath, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of skin or eyes (jaundice), extreme lethargy, sudden and severe headache, lightning headache, seizures, confusion of consciousness, visual disturbances, paralysis, urination changes.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is advisable to maintain a storage temperature of room temperature between 1°C and 30°C. This helps to safely preserve the medication's effectiveness.
White oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAtorvastatin Calcium 21.7mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Palmgen Science Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 86.8mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 10.9mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationAtorvastatin Calcium 10.85mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 21.7mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 43.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.